ArticleFrontiers in cellular and infection microbiology2016
Molecular and Phylogenetic Characterization of Non-O157 Shiga Toxin-Producing
Open access · goldAbstract read
In one paragraph
Article in Frontiers in cellular and infection microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 49 citations in OpenAlex.
- The deubiquitinase ElaD is present in the majority ofFrontiers in microbiology · 2025Article
- Shiga Toxin-ProducingPathogens (Basel, Switzerland) · 2024Article
- Rabbits as a Reservoir of Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2024Article
- Prevalence of Salmonella spp. and Escherichia coli in the feces of free-roaming wildlife throughout South Korea.PloS one · 2024Article
- Characteristics of Shiga Toxin-ProducingToxins · 2023Article
- Comparative Genetic Characterization of PathogenicAnimals : an open access journal from MDPI · 2023Article
- Prevalence and Implications of Shiga Toxin-ProducingPathogens (Basel, Switzerland) · 2022Review
- Shiga Toxin Subtypes, Serogroups, Phylogroups, RAPD Genotypic Diversity, and Select Virulence Markers of Shiga-ToxigenicMicroorganisms · 2022Article
- Antimicrobial resistance, virulence genes, and phylogenetic characteristics of pathogenic Escherichia coli isolated from patients and swine suffering from diarrhea.BMC microbiology · 2022Article
- Article
- The Importance of Shiga Toxin-ProducingMicroorganisms · 2022Article
- Prevalence and Whole-Genome Sequence-Based Analysis of Shiga Toxin-Producing Escherichia coli Isolates from the Recto-Anal Junction of Slaughter-Age Irish Sheep.Applied and environmental microbiology · 2021Article
- Antibiotic Resistance in Shiga ToxigenicAntibiotics (Basel, Switzerland) · 2021Article
- The Presence ofFrontiers in cellular and infection microbiology · 2021Article
- Genetic diversity of the intimin gene (eae) in non-O157 Shiga toxin-producing Escherichia coli strains in China.Scientific reports · 2020Article
- Article
- O-serogroups, virulence genes, antimicrobial susceptibility, and MLST genotypes of Shiga toxin-producing Escherichia coli from swine and cattle in Central China.BMC veterinary research · 2019Article
- High prevalence of non-O157 Shiga toxin-producing Escherichia coli in beef cattle detected by combining four selective agars.BMC microbiology · 2019Article
- Molecular and Phenotypic Characteristics ofBioMed research international · 2019Article
- Identification and pathogenomic analysis of an Escherichia coli strain producing a novel Shiga toxin 2 subtype.Scientific reports · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 6 institutions in 1 country.
Xiangning BaiState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention Beijing, China.
Bin HuShandong Center for Disease Control and Prevention Jinan, China.
Yanmei XuState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention Beijing, China.
Hui SunState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention Beijing, China.
Ailan ZhaoState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention Beijing, China.
Pengbin BaState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention Beijing, China.
Shanshan FuState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention Beijing, China.
Ruyue FanState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention Beijing, China.
Yujuan JinLonggang Center for Disease Control and Prevention Shenzhen, China.
Hong WangZigong Center for Disease Control and Prevention Zigong, China.
Qiusheng GuoSuixian Center for Disease Control and Prevention Suixian, China.
Xuebin XuShanghai Municipal Center for Disease Control and Prevention Shanghai, China.
Shan LuState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention Beijing, China.
Yanwen XiongState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention Beijing, China.
National Institute for Communicable Disease Control and Prevention · CNShandong Center for Disease Control and Prevention · CNShanghai Municipal Center For Disease Control Prevention · CNShenzhen Center for Disease Control and Prevention · CNXian Center for Disease Control and Prevention · CNZigong First People's Hospital · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
Shiga toxin-producing
Indexed as
Food MicrobiologyGenetic VariationSerogroupAnimalsAnimals, DomesticChinaEscherichia coli InfectionsGenotypeHumansMolecular EpidemiologyMultilocus Sequence TypingShiga-Toxigenic Escherichia coliShiga ToxinsShiga ToxinsChinaMLSTnon-O157 STECShiga toxinShiga toxin-producing E. coli
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.